May 16, 2017
“An international study of older adults has found that mass, untargeted provision of vitamin D supplements provides little clinical benefit to many when it comes to the common bone disease, osteoporosis. Instead, the study recommends targeting vitamin D supplements at individuals whose levels of this vitamin are markedly reduced.
The results of the study – carried out by researchers at the University of Auckland, New Zealand, and Harvard Medical School, Boston, MA – were announced today by Professor Ian R. Reid at ECTS 2017, the 44th European Calcified Tissue Society Congress being held in Salzburg, Austria.
Professor Reid said: ‘We know that severe vitamin D deficiency causes osteomalacia, yet trials in the community have not consistently shown that vitamin D supplements improve older adults’ bone density or reduce the risk of fracture. So we set out to determine whether a higher dose of vitamin D influences bone density or whether benefit is dependent on the level of vitamin D already present in the individual.'”